Iloperidone
NDC Package 51672-4213-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Iloperidone is a . Marketed by -sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-4213 and is authorized under FDA application ANDA207098.

Identification & Billing

NDC Package Code
51672-4213-7
Package Description
1 BLISTER PACK in 1 DOSE PACK / 1 KIT in 1 BLISTER PACK
Product Code
51672-4213
11-Digit Billing Format
51672421307

Clinical Specifications

Proprietary Name
Iloperidone
Dosage Form
-

Regulatory & Marketing

Labeler Name
-sun Pharmaceutical Industries, Inc.
FDA Application #
ANDA207098
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-22-2019
End Marketing Date
09-03-2025
Listing Expiration
09-03-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-4213-7 identifies a specific commercial package of 1 blister pack in 1 dose pack / 1 kit in 1 blister pack of Iloperidone, labeled by -sun Pharmaceutical Industries, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by -sun Pharmaceutical Industries, Inc. on July 22, 2019. The current certification is valid through September 03, 2025.

How is this -sun Pharmaceutical Industries, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672421307. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-4213-7
11-Digit CMS (5-4-2)
51672-4213-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.